Wall Street Analysts Predict 35.64% Growth Potential for Inogen (INGN): Is Such a Surge Possible?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 08 2025
0mins
Source: NASDAQ.COM
Stock Performance and Price Targets: Inogen (INGN) shares have risen 25.2% recently, with Wall Street analysts suggesting a mean price target of $11, indicating a potential upside of 35.6%, despite some estimates predicting declines.
Analyst Insights and Earnings Revisions: Analysts show growing optimism for INGN's earnings, with a Zacks Rank #2 (Buy) reflecting strong agreement on positive earnings revisions, which historically correlate with stock price movements.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on INGN
Wall Street analysts forecast INGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGN is 13.00 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.860
Low
12.00
Averages
13.00
High
14.00
Current: 5.860
Low
12.00
Averages
13.00
High
14.00
About INGN
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Inogen Launches Aurora CPAP Masks, Expanding into Sleep Therapy Market
- Product Innovation: Inogen's launch of the Aurora CPAP masks marks a significant milestone in its respiratory care portfolio, aimed at providing high-quality masks for patients with obstructive sleep apnea, thereby expanding market opportunities.
- Market Positioning: Designed for superior comfort and reliability, the Aurora masks enhance Inogen's competitiveness in the rapidly growing sleep therapy market, with plans to leverage existing distribution channels to strengthen relationships with healthcare providers.
- User Feedback: A patient-use study involving 140 participants revealed that the majority reported high satisfaction with the Aurora masks, indicating strong market acceptance and potential for sales growth.
- Technical Advantages: Featuring high-quality headgear and medical-grade silicone cushions, the Aurora masks provide a comfortable fit and are universally compatible with most CPAP devices, meeting FDA 510(k) standards for safety and performance.

Continue Reading
Inogen Launches Aurora CPAP Masks, Expanding into Sleep Apnea Market
- Product Innovation: Inogen's launch of the Aurora CPAP masks marks a significant advancement in its home respiratory solutions, aimed at addressing the needs of patients with obstructive sleep apnea, thereby broadening its market coverage.
- Market Opportunity: Designed for superior comfort and reliability, the Aurora masks are expected to enhance Inogen's competitiveness in the rapidly growing sleep therapy market, further increasing its market share.
- Customer Satisfaction: A patient-use study involving 140 participants revealed that the majority reported high satisfaction with the Aurora masks, establishing a solid foundation for Inogen's market entry.
- Strategic Partnerships: Inogen plans to leverage its existing distribution channels and partnerships to bring the Aurora masks to market, strengthening relationships with healthcare providers and reinforcing its leadership position in home respiratory care.

Continue Reading








